{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:00:13Z","timestamp":1791115213709,"version":"4.1.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.ejim.2007.11.014","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T15:24:01Z","timestamp":1205249041000},"page":"e32-e33","source":"Crossref","is-referenced-by-count":19,"title":["Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab"],"prefix":"10.1016","volume":"19","author":[{"given":"J.A.","family":"Montes-Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Callejas-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"S\u00e1nchez-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Gonz\u00e1lez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Navas-Parejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ortego-Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2007.11.014_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1468-3083.2001.00303.x","article-title":"Acne inversa (alias hidradenitis suppurativa)","volume":"15","author":"Jansen","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejim.2007.11.014_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ndt\/18.1.192","article-title":"Diarrhea, nephrotic s\u00edndrome and hidradenitis suppurativa: an unusual case","volume":"18","author":"Titze","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2007.11.014_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2006.07.027","article-title":"Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients","volume":"56","author":"Fardet","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejim.2007.11.014_bib4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archderm.142.9.1110","article-title":"The cutting edge. Severe hidradenitis suppurativa treated with adalimumab","volume":"142","author":"Moul","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejim.2007.11.014_bib5","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","article-title":"Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2007.11.014_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjmed.2005.01.028","article-title":"Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists","volume":"118","author":"Fern\u00e1ndez-Nebro","year":"2005","journal-title":"Am J Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T04:29:50Z","timestamp":1546230590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620508000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0953620508000149"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2007.11.014","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}